Joseph S. Shan
2016
In 2016, Joseph S. Shan earned a total compensation of $579K as Former Vice President, Clinical & Regulatory Affairs at Peregrine Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $122,917 |
|---|---|
| Option Awards | $105,620 |
| Salary | $300,000 |
| Other | $50,463 |
| Total | $579,000 |
Shan received $300K in salary, accounting for 52% of the total pay in 2016.
Shan also received $122.9K in non-equity incentive plan, $105.6K in option awards and $50.5K in other compensation.
Rankings
In 2016, Joseph S. Shan's compensation ranked 10,659th out of 14,075 executives tracked by ExecPay. In other words, Shan earned more than 24.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,659 out of 14,075 | 24th |
Division Manufacturing | 4,133 out of 5,489 | 25th |
Major group Chemicals And Allied Products | 1,467 out of 1,895 | 23rd |
Industry group Drugs | 1,178 out of 1,538 | 23rd |
Industry Pharmaceutical Preparations | 922 out of 1,176 | 22nd |
Source: SEC filing on August 17, 2018.
Shan's colleagues
We found three more compensation records of executives who worked with Joseph S. Shan at Peregrine Pharmaceuticals in 2016.